Niacin for people with or without established cardiovascular disease
Heart attack and stroke are the most common causes of death, illness, disability and reduced quality of life in industrialised countries, and several Cochrane Reviews look at ways to prevent these cardiovascular events. A new review from June 2017 looks at the evidence for a B-vitamin called niacin. One of the reviews' authors, Matthias Briel from Basel Institute for Clinical Epidemiology and Biostatistics in Switzerland, outlines the findings in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - March 20, 2018 Category: General Medicine Authors: Cochrane Source Type: podcasts

Is Niacin Done?
The latest research seems to settle any question of a role for niacin in the management of hyperlipidemia. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - December 18, 2014 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

Niacin With Statins? No Dice.
Wilbert Aronow comments on the trial that slammed the door on niacin for lipid-lowering. (Source: Medscape Family Medicine Podcast)
Source: Medscape Family Medicine Podcast - September 19, 2014 Category: Primary Care Authors: Medscape Source Type: podcasts

#182: ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF
ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 13, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#180: "Choosing wisely" now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol...
Choosing wisely now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol in (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 1, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#174: Niacin/laropiprant products to be suspended; JNC 8, ATP 4 guidelines; new meta-analysis on sugar sparks old debate; two antihypertensives plus NSAID ups risk of acute kidney injury
Niacin/laropiprant products to be suspended; JNC 8, ATP 4 guidelines; new meta-analysis on sugar sparks old debate; two antihypertensives plus NSAID ups risk of acute kidney injury (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - January 18, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts